SCHEMBL6774141

SCHEMBL6774141

CN(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL40860 0.81 MAPK14 (1.00) MAPK14
SCHEMBL5773810 0.81 MAPK14 (1.00) MAPK14
SCHEMBL5773320 0.78 MAPK14 (1.00) MAPK14
SCHEMBL5771909 0.77 MAPK14 (1.00) MAPK14
SCHEMBL6778439 0.77 MAPK14 (0.79) MAPK14
SCHEMBL5771778 0.76 MAPK14 (0.71) MAPK14
SCHEMBL5771772 0.75 MAPK14 (1.00) MAPK14
SCHEMBL15008027 0.75 MAPK14 (0.58) MAPK14
SCHEMBL6778310 0.74 MAPK14 (0.74) MAPK14
SCHEMBL21631838 0.73 MAPK14 (0.83) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6696464-B2 POTENT INHIBITORS OF MAP KINASES, PREFERABLY P38 KINASE; USEFUL IN TREATMENT OF INFLAMMATION, OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, CANCER, REPERFUSION OR ISCHEMIA IN STROKE OR HEART ATTACK PFIZER INC 2004-02-24 US disclosed